These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 17472698)
1. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents. Mizoguchi H; Yamada K; Nabeshima T J Pharmacol Sci; 2008 Jan; 106(1):9-14. PubMed ID: 18198472 [TBL] [Abstract][Full Text] [Related]
3. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice. Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864 [TBL] [Abstract][Full Text] [Related]
4. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235 [TBL] [Abstract][Full Text] [Related]
5. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens. Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193 [TBL] [Abstract][Full Text] [Related]
6. Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization. Cen X; Nitta A; Ibi D; Zhao Y; Niwa M; Taguchi K; Hamada M; Ito Y; Ito Y; Wang L; Nabeshima T Mol Psychiatry; 2008 Apr; 13(4):349, 451-63. PubMed ID: 18195717 [TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens. Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348 [TBL] [Abstract][Full Text] [Related]
8. Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine. Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K PLoS One; 2012; 7(4):e35494. PubMed ID: 22530033 [TBL] [Abstract][Full Text] [Related]
9. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect. Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589 [TBL] [Abstract][Full Text] [Related]
10. Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats. Narita M; Akai H; Kita T; Nagumo Y; Narita M; Sunagawa N; Hara C; Hasebe K; Nagase H; Suzuki T Neuroscience; 2005; 132(3):553-60. PubMed ID: 15837117 [TBL] [Abstract][Full Text] [Related]
11. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism. Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice. Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405 [TBL] [Abstract][Full Text] [Related]
13. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657 [TBL] [Abstract][Full Text] [Related]
14. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice. Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655 [TBL] [Abstract][Full Text] [Related]
16. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726 [TBL] [Abstract][Full Text] [Related]
17. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence. Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274 [TBL] [Abstract][Full Text] [Related]
18. Dopamine D Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803 [TBL] [Abstract][Full Text] [Related]
19. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice. Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906 [TBL] [Abstract][Full Text] [Related]
20. Depletion of D3 dopamine receptor affects methamphetamine-induced expression patterns of Pde4b and Atf3. Chen Y; Yang C; Zhu L; Li J; Guan F; Chen T Neurosci Lett; 2018 Feb; 665():54-60. PubMed ID: 29175029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]